Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma - Wikidata - wikimedia - TriplyDB

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

http://www.wikidata.org/entity/Q35131811

about

Leucine zipper domain is required for Kaposi sarcoma-associated herpesvirus (KSHV) K-bZIP protein to interact with histone deacetylase and is important for KSHV replication Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells Human herpesvirus 8--a novel human pathogen Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysis Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus DNA Tumor Viruses and Cell Metabolism Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA The Role of Gammaherpesviruses in Cancer Pathogenesis KSHV: pathways to tumorigenesis and persistent infection Enhanced response of T cells from murine gammaherpesvirus 68-infected mice lacking the suppressor of T cell receptor signaling molecules Sts-1 and Sts-2 A Structural Basis for BRD2/4-Mediated Host Chromatin Interaction and Oligomer Assembly of Kaposi Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus LANA Proteins Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses Molecular virology of Kaposi's sarcoma-associated herpesvirus Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1 Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Pathologic aspects of AIDS malignancies.Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Distinct roles for extracellular signal-regulated kinase 1 (ERK1) and ERK2 in the structure and production of a primate gammaherpesvirus Tracking expression and subcellular localization of RNA and protein species using high-throughput single cell imaging flow cytometry.Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells.Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.

P2860

Q24307542-780AE4D4-EEEF-4C9F-8392-52AA73EE2DDE Q24527215-16F5D9E9-3431-463B-A927-A8FB05FBC214 Q24530670-EEC3E96D-EF15-4BA8-855C-E02E6263701C Q24538878-567C2A25-6888-459D-AC78-E41A48A6731B Q24543014-6B84278F-58F9-4975-8099-D811D7FFE705 Q24646461-130B3C56-BFB6-4BC8-8799-3806D93890C9 Q24670086-ADFA5BAC-0219-4D49-9528-1DD7F1D1321D Q24673299-448C8CC9-F239-4B54-897D-87C88769DAD5 Q24673761-9B41E244-09EF-40D7-9509-55CDD1ECDAEB Q24683297-BD2DAF89-716B-47A9-9798-775D198F1255 Q24805204-37454119-F37D-4BA1-AE9B-839D42B222E9 Q24809576-F9D8AEF6-05FA-4A3B-9D17-987C1B319832 Q26743368-E476153A-FB1D-4289-B488-F96E3BE172A5 Q26749066-4E2445F2-B7C2-4EA2-AA75-0A496D5BDFA4 Q26749612-2C6F538F-9090-4C9B-A544-54B839D7DD34 Q26767186-15C49468-B2D1-4885-9F44-FB84D5F5D85B Q27026000-C0B89AEA-4EE1-46B0-8DEA-7E1ECA5D29F4 Q27318672-CF57DE49-AA22-43DA-B76B-6A0C024A60D7 Q27680409-53569664-4BC6-4AC9-9332-4CDF569DF963 Q28080898-2EAD2917-8C2A-425A-99FC-BF5C821D15EF Q28363323-5A9DE288-3FC5-48F7-AD17-AB0EEFF22AA0 Q28393661-7E14F6D3-B6F2-4DD4-981A-189F38681523 Q28472699-9B7D5BD6-E030-4B77-98F6-862140B76AC6 Q28472867-6E650BA2-14DF-442B-A9F1-BE69C8A86F9A Q28540116-FE1ADF1B-74E5-423C-8260-114ED266393A Q29394711-33BF0DCA-1EED-43FA-A119-60F5AD03B1CB Q30336144-D7370FA4-5EA5-4288-B698-F3EDBE941B22 Q30357883-3E7DDE80-2EA5-437C-899D-5E9B5140D448 Q30422254-B20F332E-2428-492B-939A-E3CE0A530276 Q30425660-13A824BF-2989-48E7-97F7-562666988B7C Q30919397-29DD0F7F-D314-4872-9E76-39CDA5B93C42 Q30982439-F5509554-49D6-4EAF-9759-28A59995DB71 Q33221441-F1EF015C-331B-47A7-9DFC-D5240B17122C Q33386690-797F5CC6-5A93-4086-A842-BCE62E23E583 Q33432690-0CCF8295-5B76-41B5-8755-F2EE15351960 Q33509506-DEF26C6E-9ED9-40E6-AC9B-7E67B7F3A529 Q33560572-22567947-05C6-41EC-A276-13B1230BAC2A Q33571183-930393A1-D90C-465B-AD50-01C24346458F Q33598569-1DB38435-C235-4407-9A94-EFD8DBD5CF52 Q33648307-C28757C2-6325-4EB5-A312-37742464A4BD

P2860

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

http://www.wikidata.org/entity/Q35131811

description

1999 nî lūn-bûn

@nan

1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Distribution of human herpesvi ...... and primary effusion lymphoma

@ast

Distribution of human herpesvi ...... and primary effusion lymphoma

@en

type

label

Distribution of human herpesvi ...... and primary effusion lymphoma

@ast

Distribution of human herpesvi ...... and primary effusion lymphoma

@en

prefLabel

Distribution of human herpesvi ...... and primary effusion lymphoma

@ast

Distribution of human herpesvi ...... and primary effusion lymphoma

@en

P1433

Q35131811-1C05BD38-3AB5-4492-9A7E-9063B8149EB2

P1476

Q35131811-6F7D9420-02BC-4822-B92D-B18F5072400E

P2093

Q35131811-1B797975-0F11-49ED-9063-729A0D2F55A9

Q35131811-30C10F10-0205-4F17-984B-34E488411B8F

Q35131811-39FEE640-F992-4E03-8D27-BCC78ABE05A4

Q35131811-5EAC3456-9F4D-462A-A805-348438369B81

Q35131811-6935BBC5-4721-402D-91B2-880B6DD0426B

Q35131811-8D55C0C2-16C5-4312-BD56-E83202A79469

Q35131811-ABCA0408-63C9-4F49-8D98-352369F0D0D0

Q35131811-CABBA616-A6D1-4BA4-B7EB-6B2FC4C6F4D8

Q35131811-CCAF6D9D-E037-4327-B3CE-BDF7965E39E7

Q35131811-ECF377BE-046F-4986-8219-06B2C2F49B1D

P2860

Q35131811-04BD1970-FB66-46B6-9C53-09419CADA5F8

Q35131811-0F646829-B603-4664-9F03-83387E8E1B06

Q35131811-11ECA3F3-64CE-4806-8653-6EF58D0BD0DA

Q35131811-1D92E6CD-9BCD-403C-A6B9-F91D8895A659

Q35131811-20A608B4-7C9F-404E-997C-B20966C6134C

Q35131811-20E46FDB-D30A-4D48-8B28-8F6A32440630

Q35131811-218C477A-1158-4A7B-AB44-9F2D1EAF5FFE

Q35131811-24DDB41B-3199-426D-A9CC-D9063CD19C90

Q35131811-25D95351-78B6-4F66-BC6D-1D9C2ADF5524

Q35131811-3161CD89-27D7-4109-9B0A-30F7C60AD261

P304

Q35131811-2CA1CBE2-3811-4D48-92CB-2172CB38BDD6

P31

Q35131811-723E1CE2-9F9B-4DFC-834C-ED85CE69DE57

P356

Q35131811-1766D6B4-3A5D-43E2-9175-7DB816DFD934

P407

Q35131811-7FF21B0C-1CAA-4A70-BA7F-610E0627281B

P433

Q35131811-62D22375-A609-4060-9F2F-BE2167080744

P478

Q35131811-718603F1-B366-4E2B-BBDF-432F163A51C7

P50

Q35131811-15CE3464-2A07-4517-9D56-664580050C32

Q35131811-30AFE636-96C0-4D4F-9DA6-5A4ACA73120B

Q35131811-43416651-645D-43FF-8A4C-B38BB87FD88C

P577

Q35131811-A8B30958-92DF-4DBE-AB65-7A5C544B0610

P5875

Q35131811-BB90520F-8B80-49FF-BA63-E30B72994F36

P698

Q35131811-F72D3C43-C6C1-4620-8FE8-3246F55534C2

P932

Q35131811-8BA11C90-71DC-4693-953E-C6425E7C1FED

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Distribution of human herpesvi ...... and primary effusion lymphoma

@en

P2093

C Boshoff

http://www.w3.org/2001/XMLSchema#string

C Fisher

http://www.w3.org/2001/XMLSchema#string

D Salmon

http://www.w3.org/2001/XMLSchema#string

E van Marck

http://www.w3.org/2001/XMLSchema#string

I Gorin

http://www.w3.org/2001/XMLSchema#string

J P Escande

http://www.w3.org/2001/XMLSchema#string

M Tulliez

http://www.w3.org/2001/XMLSchema#string

N Franck

http://www.w3.org/2001/XMLSchema#string

R A Weiss

http://www.w3.org/2001/XMLSchema#string

S Ariad

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development

Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease

Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.

Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells.

P304

4546-4551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.8.4546

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

P577

1999-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

242906863

http://www.w3.org/2001/XMLSchema#string

P698

10200299

http://www.w3.org/2001/XMLSchema#string

P932

16369

http://www.w3.org/2001/XMLSchema#string